amphotericin B deoxycholate
Selected indexed studies
- Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function. (Cochrane Database Syst Rev, 2015) [PMID:26595825]
- Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting. (Pediatr Infect Dis J, 2014) [PMID:24618932]
- Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. (Drugs, 2016) [PMID:26818726]
_Worker-drafted node — pending editorial review._
Connections
amphotericin B deoxycholate is a side effect of
Sources
- Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function. (2015) pubmed
- Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting. (2014) pubmed
- Liposomal Amphotericin B (AmBisome(®)): A Review of the Pharmacokinetics, Pharmacodynamics, Clinical Experience and Future Directions. (2016) pubmed
- Amphotericin B. (2026) pubmed
- Candida urinary tract infections in adults. (2020) pubmed
- Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice? (2011) pubmed
- Amphotericin B Deoxycholate Treatment of Post-Kala-Azar Dermal Leishmaniasis in India. (2024) pubmed
- Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment. (2011) pubmed
- [Expert consensus on rational clinical application of amphotericin B deoxycholate (2022)]. (2023) pubmed
- [Amphotericin B deoxycholate (Fungizone): old drug, new versions]. (1997) pubmed